MediciNova, Inc. (MNOV)
1.37
-0.02
(-1.44%)
USD |
NASDAQ |
May 21, 16:00
MediciNova EPS Diluted (Quarterly) : -0.0525 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | 2.153 |
| Cytokinetics, Inc. | -1.671 |
| Ionis Pharmaceuticals, Inc. | -0.5612 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.586M |
| Revenue (Quarterly) | 0.187M |
| Total Expenses (Quarterly) | 2.773M |
| Enterprise Value | 40.27M |
| Gross Profit Margin (Quarterly) | 6.74% |
| Profit Margin (Quarterly) | -1.38K% |
| Earnings Yield | -17.42% |
| Normalized Earnings Yield | -17.42 |